FDA Removes Regulatory Overhang From Inhibikase Therapeutics Parkinson/Atrophy Program By: Benzinga via Benzinga March 08, 2023 at 11:41 AM EST The FDA lifted the full Clinical Hold onInhibikase Therapeutics Inc's(NASDAQ: IKT) IkT-148009, the company's ... Read More >> Related Stocks: Inhibikase Therapeutics Inc